Table 3.

Light chain Jk gene usage and Jk sequences of 6-19–like IgG3 anti-IgG2a RF mAb derived from 6-19 heavy-chain transgenic mice

FusionmAb3-150JkJk sequence
 6-19 Jk2′ YTFGSGTKLEIK 
A6C Jk2′ ------------ 
 G1H Jk2 ----G------- 
 S1B Jk4 F----------- 
 C12A Jk1 P---G------- 
II P11C Jk2′ ------------ 
 E21A Jk1 R---G------- 
 Q4C Jk1 W---G------- 
 R11A Jk4 ●---T-------- 
 L10H Jk4 F---T------- 
 D6G Jk5 L---A-----L- 
III Y12C Jk2′ ------------ 
 Z5C Jk1 W---G------- 
FusionmAb3-150JkJk sequence
 6-19 Jk2′ YTFGSGTKLEIK 
A6C Jk2′ ------------ 
 G1H Jk2 ----G------- 
 S1B Jk4 F----------- 
 C12A Jk1 P---G------- 
II P11C Jk2′ ------------ 
 E21A Jk1 R---G------- 
 Q4C Jk1 W---G------- 
 R11A Jk4 ●---T-------- 
 L10H Jk4 F---T------- 
 D6G Jk5 L---A-----L- 
III Y12C Jk2′ ------------ 
 Z5C Jk1 W---G------- 
F3-150

The 6-19 monoclonal antibody (mAb) is derived from an MRL-Faslpr mouse.17 The 6-19–like IgG3 anti-IgG2a RF mAbs bearing the 6-19 idiotype, resulting from the combination of the transgenic 6-19 heavy chains with endogenous light chains, were established from 3 independent fusions by using spleen cells from 6-19 heavy-chain transgenic mice, and all of them utilize the Vk1c gene segment identical to that of the 6-19 mAb. †Dashes refer to amino acid residue identical to the 6-19 Jk sequence, and a gap is indicated by a dot.

or Create an Account

Close Modal
Close Modal